EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications

Bin-Can Tang iD, Ya-Ting Wang iD, Jie Ren

Ibrain · 2023-09 · 9 (3) · 340-348

DOI: 10.1002/ibra.12098 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ibrain, online erschienen am 06.06.2023. Verfasst von Bin-Can Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology Southwest Medical University Luzhou China. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Memantine is a noncompetitive moderate‐affinity strong voltage‐dependent N‐methyl‐D‐aspartate receptor antagonist. It has been used to treat Alzheimer's disease (AD) since 1989. In 2018, it became the second most commonly used drug for the treatment of dementia in the world. AD is nonreversible, and memantine can only relieve the symptoms of AD but not cure it. Over the past half‐century, memantine's research and clinical application have been extensively developed. In this review, the basic composition of memantine, the mechanism and limitations of memantine in the treatment of AD, memantine combination therapy, comparison of memantine with other drugs for AD, and clinical studies of memantine in other diseases are reviewed to provide a valuable reference for further research and application of memantine for the treatment of AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseN‐methyl‐D‐aspartate receptormemantine

Autor:innen und Institutionen

  • Department of Anesthesiology Southwest Medical University Luzhou China.
  • Department of Neuroscience The University of Sheffield Sheffield UK.

ORCID-Profile: Bin-Can Tang, Ya-Ting Wang

Zitieren

APA

Tang, B. C., Wang, Y. T., & Ren, J. (2023). Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications. Ibrain, 9(3), 340-348. https://doi.org/10.1002/ibra.12098

Vancouver

Tang BC, Wang YT, Ren J. Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications. Ibrain. 2023;9(3):340-348. doi:10.1002/ibra.12098

BibTeX
@article{Tang2023,
  author = {Tang, Bin-Can and Wang, Ya-Ting and Ren, Jie},
  title = {Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications},
  journal = {Ibrain},
  year = {2023},
  volume = {9},
  number = {3},
  pages = {340--348},
  doi = {10.1002/ibra.12098}
}
Kostenlos starten →